T1	Participants 104 133	peripheral pulmonary lesions:
T2	Participants 485 561	Two hundred two patients with PPLs and positive EBUS findings were enrolled.
T3	Participants 900 1006	A total of 182 patients (94 in the EBUS CDPs group and 88 in the EBUS-TBNA plus CDPs group) were analyzed.
